CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Prilosec OTC (omeprazole-magnesium) +1 moredrug
Likely dose
Prilosec OTC (omeprazole-magnesium) 20.6 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00903448
NCT00903448Phase 4Completed
CompareCT.gov

Comparison of Prilosec OTC® Versus Prevacid ® for Gastric Acid Suppression

Procter and Gamble·interventional·Posted May 18, 2009·Updated Dec 31, 2010

In Brief

A Phase 4 clinical trial evaluating Prilosec OTC (omeprazole-magnesium) and Prevacid for Healthy. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 18, 2009
Enrollment StartApr 1, 2009
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.1 years ago

Interventions

Prilosec OTC (omeprazole-magnesium)drug

Prilosec OTC (omeprazole-magnesium 20.6 mg) tablet to be taken with a glass of water prior to breakfast

Prevaciddrug

Prevacid (15 mg lansoprazole) capsule to be taken with a glass of water prior to breakfast